{{Rsnum
|rsid=10786828
|Gene=SORCS3
|Chromosome=10
|position=106609900
|Orientation=plus
|GMAF=0.4747
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 23.9 | 46.0 | 30.1
| HCB | 6.6 | 34.3 | 59.1
| JPT | 10.6 | 36.3 | 53.1
| YRI | 72.8 | 23.8 | 3.4
| ASW | 61.4 | 35.1 | 3.5
| CHB | 6.6 | 34.3 | 59.1
| CHD | 5.5 | 52.3 | 42.2
| GIH | 36.6 | 51.5 | 11.9
| LWK | 70.0 | 27.3 | 2.7
| MEX | 17.2 | 37.9 | 44.8
| MKK | 44.9 | 44.9 | 10.3
| TSI | 21.6 | 52.0 | 26.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs10786828
|Name_s=
|Gene_s=SORCS3
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363853
}}

{{PMID Auto
|PMID=21283786
|Title=Global analysis of the impact of environmental perturbation on cis-regulation of gene expression.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10786828
|overall_frequency_n=53
|overall_frequency_d=128
|overall_frequency=0.414062
|n_genomes=30
|n_genomes_annotated=0
|n_haplomes=37
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}